共 35 条
- [1] Heart Disease and Stroke Statistics - 2003 Update, (2002)
- [2] Towbin J.A., Bowles N.B., Genetic abnormalities responsible for dilated cardiomyopathy, Curr. Cardiol. Rep., 2, pp. 475-480, (2000)
- [3] Bachinski L.L., Roberts R., New theories: Causes of dilated cardiomyopathy, Cardiol. Clin., 16, pp. 603-610, (1998)
- [4] Mestroni L., Rocco C., Vatta M., Miocic S., Giacca M., Advances in molecular genetics of dilated cardiomyopathy, Cardiol. Clin., 16, pp. 611-621, (1998)
- [5] Kearney M.T., Cotton J.M., Richardson P.J., Shah A.M., Viral myocarditis and dilated cardiomyopathy: Mechanisms, manifestations, and management, Postgrad. Med. J., 77, pp. 4-10, (2001)
- [6] Gluck B., Schmidtke M., Merkle L., Stelzner A., Gemsa D., Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice, J. Mol. Cell. Cardiol., 33, pp. 1615-1626, (2001)
- [7] Habib F.M., Springall D.R., Davies G.J., Oakley C.M., Yacoub M.H., Polak J.M., Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy, Lancet, 347, pp. 1151-1155, (1996)
- [8] Lipshultz S.E., Dilated cardiomyopathy in HIV-infected patients, N. Engl. J. Med., 339, pp. 1153-1155, (1998)
- [9] Barbara G., Lipshultz S.E., Pathogenesis of HIV-associated cardiomyopathy, Ann. NY Acad. Sci., 946, pp. 57-81, (2001)
- [10] Fisher S.D., Lipshultz S.E., Epidemiology of cardiovascular involvement in HIV disease and AIDS, Ann. NY Acad. Sci., 946, pp. 13-22, (2001)